Aura Biosciences (AURA) Insider Trading & Ownership $11.39 -0.26 (-2.23%) (As of 10/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aura Biosciences (NASDAQ:AURA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$14.58 MNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.07 M AURA Insider Buying and Selling by Quarter Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Aura Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/18/2024Julie B FederCFOSell25,131$12.03$302,325.93 10/18/2024Los Pinos Elisabet DeInsiderSell24,992$12.04$300,903.68 10/16/2024Mark PlavsicCTOSell7,383$9.85$72,722.55 1/23/2024Julie B FederCFOSell6,609$7.64$50,492.76 1/23/2024Los Pinos Elisabet DeInsiderSell15,853$7.64$121,116.92 11/9/2023Matrix Capital Management CompMajor ShareholderBuy1,560,000$9.00$14,040,000.00 The real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows,11/7/2023David Michael JohnsonDirectorBuy76,000$7.17$544,920.00 11/6/2023Julie B FederCFOSell3,900$12.07$47,073.00 11/6/2023Los Pinos Elisabet DeInsiderSell7,449$12.03$89,611.47 10/30/2023Julie B FederCFOSell3,385$6.82$23,085.70 10/30/2023Los Pinos Elisabet DeInsiderSell9,586$6.83$65,472.38 (Data available from 1/1/2013 forward) AURA Insider Trading Activity - Frequently Asked Questions Who is on Aura Biosciences's Insider Roster? The list of insiders at Aura Biosciences includes Cadmus Rich, David Michael Johnson, Julie B Feder, Los Pinos Elisabet De, Mark Plavsic, Matrix Capital Management Comp, and Rosch Mark De. Learn more on insiders at AURA. What percentage of Aura Biosciences stock is owned by insiders? 5.40% of Aura Biosciences stock is owned by insiders. Learn more on AURA's insider holdings. Which Aura Biosciences insiders have been buying company stock? The following insiders have purchased AURA shares in the last 24 months: David Michael Johnson ($823,225.00), and Matrix Capital Management Comp ($29,040,000.00). How much insider buying is happening at Aura Biosciences? Insiders have purchased a total of 2,913,896 AURA shares in the last 24 months for a total of $29,863,225.00 bought. Which Aura Biosciences insiders have been selling company stock? The following insiders have sold AURA shares in the last 24 months: Cadmus Rich ($20,816.40), Julie B Feder ($448,064.14), Los Pinos Elisabet De ($577,104.45), Mark Plavsic ($72,722.55), and Rosch Mark De ($13,892.90). How much insider selling is happening at Aura Biosciences? Insiders have sold a total of 109,090 Aura Biosciences shares in the last 24 months for a total of $1,132,600.44 sold. Aura Biosciences Key ExecutivesDr. Elisabet de los Pinos Ph.D. (Age 51)Founder, CEO, President & Director Compensation: $795.3kMs. Julie B. Feder (Age 54)CFO, Secretary & Treasurer Compensation: $505.45k1 recent tradesMr. Patrick NealonSenior Vice President of Clinical Development OperationsDr. Bruce Brown M.D.Senior VP & Therapeutic Area Head of Urologic OncologyDr. Anthony Daniels M.D.Therapeutic Area Head of Ocular OncologyDr. Richard Mountfield Ph.D.Senior Vice President of Regulatory Affairs & Quality More Insider Trading Tools from MarketBeat Related Companies UroGen Pharma Insider Buying Personalis Insider Buying Karyopharm Therapeutics Insider Buying Chimerix Insider Buying Omega Therapeutics Insider Buying Kiniksa Pharmaceuticals Insider Buying Intellia Therapeutics Insider Buying Mirum Pharmaceuticals Insider Buying Arvinas Insider Buying NewAmsterdam Pharma Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideInsiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 Stocks This page (NASDAQ:AURA) was last updated on 10/23/2024 by MarketBeat.com Staff From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored$20 = Ounce of Gold?I've discovered a way to get exposure to MORE than an ounce of gold... for under $20. It's not bullion. It'...Monument Traders Alliance | SponsoredDon’t Miss Out: Elon’s Game-Changing InventionThis is Elon Musk's latest AI innovation… According to Eric Fry, a seasoned expert with 30 years of experie...InvestorPlace | SponsoredNext opportunity for crypto millionsAs we enter crypto's golden quarter (October-December), this coin is primed for takeoff. The best part? Mos...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored[INSIDE] The $16 “AI stock” set to soarThere's one tiny firm that's providing the backbone of the entire AI sector. It's at the heart of $85 trill...Behind the Markets | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredElection rigged? We caught them red-handed…What happens if NOBODY will be elected the next President of the United States on Nov. 5? Not Donald Trump...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Aura Biosciences, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Aura Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.